BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Receivables - Net (2021 - 2026)

Updated

BridgeBio Pharma's Receivables - Net was $254.48 million in Q2 2026, up 231.1% from $76.87 million a year earlier and up 24.0% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Receivables - Net (2021 - 2026) Analysis & Trends

At the end of FY2025, Receivables - Net at BridgeBio Pharma came in at $139.44 million.

  • In earlier years, Receivables - Net was $4.72 million in FY2024 (+169.7%) and $1.75 million in FY2023.
  • The Q2 2026 figure marks the highest quarterly Receivables - Net in data going back to Q2 2021.
  • Per Business Quant data, BBIO's Receivables - Net in the three quarters before Q2 2026 was $205.23 million (Q1 2026), $139.44 million (Q4 2025) and $116.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 254.48 Mn
Mar 31, 2026 205.23 Mn
Dec 31, 2025 139.44 Mn
Sep 30, 2025 116.52 Mn
Jun 30, 2025 76.87 Mn
Mar 31, 2025 115.27 Mn
Dec 31, 2024 4.72 Mn
Dec 31, 2023 1.75 Mn
Jun 30, 2021 1.21 Mn
API Access

BridgeBio Pharma Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=BBIO&period=max&api_key=YOUR_API_KEY